Home / Share Price Target / Parmax
Parmax Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Parmax Pharma Limited | |||
 | Symbol: PARMAX | ||
| Price: ₹48.98 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Parmax Pharma Financial Performance
- 0.1.1: Is Parmax Pharma A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Parmax Pharma Share Price Target For 2024
- 1.1.1: Parmax Pharma Share Price Target Table For 2024
- 1.1.2: Summary: Parmax Pharma Share Price Prediction For 2024
- 1.2: Parmax Pharma Share Price Target For 2025
- 1.2.1: Parmax Pharma Share Price Target Table For 2025
- 1.2.2: Summary: Parmax Pharma Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Parmax Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Parmax Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Parmax Pharma Past Performance
Parmax Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 11.59 Crore | Market valuation of Parmax Pharma's shares. |
| Revenue (TTM) | 15.42 Crore | Total revenue generated by Parmax Pharma over the past twelve months. |
| Net Income (TTM) | -10.4 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 2.77% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 42.72% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -67.38% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 1.72 | Company's total debt divided by total shareholder equity. |
| Total Debt | 5.48 Crore | Sum of Parmax Pharma's current & long-term financial obligations. |
Is Parmax Pharma A Good Buy For Long Term?
While Parmax Pharma's past 5-year returns have been impressive (78.78%), its recent performance raises concerns. With a significant revenue decline (-67.38%), negative profit margin (-42.72%), and substantial debt (5.48 Crore), the company faces challenges that may impact its long-term growth prospects. Given these factors, it is not advisable to consider Parmax Pharma as a strong buy at this time.
To predict the Parmax Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Parmax Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Parmax Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Parmax Pharma shares in 2024, see the table below.
Parmax Pharma Share Price Target Table For 2024
| Parmax Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 51.49 (+5.12%) | Custom Fibonacci Extension Lvl 64.9% |
| 2024 Target 2 | 50.63 (+3.36%) | Price Action: 11 Nov 2024 High |
| 2024 Target 1 | 49.89 (+1.85%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 48.98 | Parmax Pharma's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 48.70 (-0.58%) | Price Action: Chart |
| Stop Loss 2 | 48.00 (-2.01%) | Price Action: 01 Nov 2024 High |
| Stop Loss 3 | 47.07 (-3.9%) | Fibonacci Retracement Level 50% |
Summary: Parmax Pharma Share Price Prediction For 2024
In summary, Parmax Pharma has surged by ₹16.41, achieving a notable +50.38% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Parmax Pharma for 2024 predicts an additional rise of 1.85% to 5.12% by the end of 2024 with three potential targets T1: 49.89, T2: 50.63, T3: 51.49. Stop Loss at SL1: 48.70, SL2: 48.00, SL3: 47.07.
Parmax Pharma has a 52-week high of ₹54.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹24.18, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Parmax Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Parmax Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Parmax Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Parmax Pharma shares in 2025, see the table below.
Parmax Pharma Share Price Target Table For 2025
| Parmax Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 66.82 (+36.42%) | Fibonacci Extension Level 171.8% |
| 2025 Target 2 | 65.74 (+34.21%) | Price Action: Chart |
| 2025 Target 1 | 65.09 (+32.89%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 48.98 | Parmax Pharma's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 45.14 (-7.84%) | Price Action: Nov 2024 Low |
| Stop Loss 2 | 44.69 (-8.76%) | Price Action: Chart |
| Stop Loss 3 | 43.90 (-10.38%) | Price Action: Oct 2022 High |
Summary: Parmax Pharma Share Price Prediction For 2025
In summary, Parmax Pharma has surged by ₹16.41, achieving a notable +50.38% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Parmax Pharma for 2025 predicts an additional rise of 32.89% to 36.42% by the end of 2025 with three potential targets T1: 65.09, T2: 65.74, T3: 66.82. Stop Loss at SL1: 45.14, SL2: 44.69, SL3: 43.90.
Parmax Pharma has a All-Time high of ₹81.90, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹24.18, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Parmax Pharma, we have created a specific page for that check here: Parmax Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Parmax Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Parmax Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 16.87% over the next 15 years.
For complete year by year Parmax Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Parmax Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Parmax Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹48.98 | [Current Price] |
| 2024 | ₹53.11 | 8.43% |
| 2025 | ₹79.55 | 49.78% |
| 2026 | ₹112.66 | 41.62% |
| 2027 | ₹133.87 | 18.82% |
| 2028 | ₹166.05 | 24.03% |
| 2029 | ₹198.61 | 19.6% |
| 2030 | ₹220.32 | 10.93% |
| 2031 | ₹259.92 | 17.97% |
| 2032 | ₹272.58 | 4.87% |
| 2033 | ₹308.57 | 13.2% |
| 2034 | ₹344.1 | 11.51% |
| 2035 | ₹361.1 | 4.94% |
| 2036 | ₹407.17 | 12.75% |
| 2037 | ₹411.3 | 1.01% |
| 2038 | ₹451.1 | 9.67% |
| 2039 | ₹470.83 | 4.37% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Parmax Pharma Past Performance
- In 2017, Parmax Pharma opening price was ₹12.5
- As of Tue 19 Nov 2024 the price stands at ₹48.98.
- This represents a Compound Annual Growth Rate (CAGR) of 18.61%.
- In 7 years, an investment of 10,000 would have become ₹39,184.
As we wrap up, we hope you like our study on Parmax Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
